This article provides Section 2 of the 2017 Edition 2 Medical Writing Competency Model that describes the knowledge, skills, abilities, and behaviors that professional medical writers need in order to perform effectively within the life sciences industry. What a medical writer should know, what they should be able to do, and how they should use this knowledge and these skills to facilitate their primary work function is a focus. Regulatory, publication, and other scientific writing as well as management of writing activities are covered. The full Model also includes Section 1, which covers the core work functions and associated tasks and activities related to professional medical writing within the life sciences industry; Section 1 is included in a companion article. The Model was developed to aid medical writers and managers within the life sciences industry regarding medical writing hiring, training, expectation and goal setting, performance evaluation, career development, retention, and role value sharing to cross-functional partners.
Introduction
The Medical Writing Competency Model (hereafter, the Model) consists of 2 main sections. Section 2, which is the focus of this article, describes the knowledge, skills, abilities, and behaviors that professional medical writers need in order to perform effectively within the life sciences industry and related organizations. The Model encompasses regulatory, publication, other related scientific writing, and management of writing knowledge and activities. Section 1 of the Model includes the core work functions, tasks, and activities associated with medical writing and is presented in a companion article. 1 The Model was developed to aid medical writers and managers within the life sciences industry in regard to hiring, training, setting expectations and goals, performance evaluation, career development, and retention. 2, 3 Presently, the Model does not differentiate the competencies of novice from experienced writers or role levels. However, the Model can be used to develop associated tools that would allow delineation of experience levels. 2, 3 In 2008-2009, the Drug Information Association (DIA) Medical Writing Community formed a working group that developed the Model. 4 The group consisted of global experts from across organization types and medical writing niches. A new working group was organized in 2016-2017 to update the Model (2nd Edition) because of the changing needs within the life sciences industry and ongoing evolution of the medical writing role.
The Model is purposely inclusive because of the scope and breadth of professional medical writing today. Thus, users of the Model should focus on what is applicable to them based upon their specific needs. For example, Model content focus will vary whether the information is needed for a regulatory or publication writer, an industry or freelance writer, to help with organizational development or hiring practice, or to aid in role communication or training plan development. The Model covers the entire range of competencies across the wide variety of medical writer types and their various employment roles. While all medical writers require a minimal common knowledge and skill set to be successful, an individual topic or skill may be more important for one medical writer than for another depending upon the individual's specific circumstances or work requirements.
It is also important for medical writers to have a broad understanding of the relevance of topics included in the Model to be successful, even if a topic is not core to their current role. This is particularly important because there is often a problematic misconception that medical writers have a knowledge base and skill set (ie, competency) that are common across life science industry employees. 5 To the contrary, medial writing is different from other writing disciplines, is generally not taught in school, and requires additional ongoing professional training. This lack of understanding often can devalue a professional medical writer's contributions. The Model is organized into 3 sections. The first section, published separately, 1 is the core of the Model and describes medical writing work by work functions, tasks, and activities.
The second section, presented in this article, details the knowledge (what one should know), skills/abilities (what one should be able to do), and behaviors (how one should demonstrate knowledge and skills) needed for all medical writers to facilitate the primary work functions. This information is also provided for regulatory writers, publication writers, and managers of medical writers. Team/peer review (assess the quality and completeness of scientific content and specific research methods; ensure alignment of the document with agreed-upon key messages and overall expectations) Quality review/check (check document against source); fact or data check (verify one set of data against another; verifying the accuracy of information and claims); check styles, hyperlinks, bookmarks, headers/footers, and metadata for e-publishing; complete related checklists Regulatory review (verify adherence to requirements and standards) Statistical review (evaluate statistical presentations and general research methods) 24 Translate (transcribe) documents from one language to another, appropriately and accurately expressing the content, including:
Conform to American, British, or Indian English language, based upon local need 25 Write original documents in local language, as required by some local (eg, Asian) regulatory agencies and journals Behaviors 1 Act with the highest ethical standard 2
Adapt to changes in a complex, changing environment 3
Be driven by results and performance with a bias for proactive action 4
Be commercially astute 5
Build positive and productive relationships Regulatory authority laws, regulations, policies, and guidance, including: Clinical, nonclinical, and CMC requirements to support major regulatory filings, including: e-Submission (eg, STF) HCP interaction Labeling (eg, SPL and PLR) NDA, BLA, PMA, 351(K), and 510(k) submissions for marketing clearance for drugs, biologics, biosimilars, and devices Transparency requirements for public disclosure of regulatory documents, including:
EMA Policy 0070, including expectations for anonymization of PPD and redaction of CCI CTR requirements, with expectations for trial registration, status reporting, and results reporting, including:
ClinicalTrial.gov, as required in US by FDAAA final rule EudraCT, as required in EU by EMA Regional authority/agency specific guidance, including: Canada (TPD) EU (EMA/CHMP) GCC-DR Japan (MHLW/PMDA) Pan-regional Asia: China (CFDA), Korea (MFDS), Taiwan (TFDA), and ASEAN US (FDA CFR) The third section provides additional information, including general abilities for all medical writers (Table S1 ) and the five core competency domains of the Medical Writer Certified (MWC ) 2016 Examination Content Outline (Table S2) . 6 The list of general abilities presents a high-level, all-purpose summary of characteristics relevant for medical writers. The MWC domains provide a competency summary identifying minimal levels of core knowledge and skills for a professional medical writer that aids in delineating the needs of more novice writers/roles. Table 1 lists the abbreviations used in this article, as abbreviations are not spelled out in the text.
Within the model, document is used as a comprehensive term to include the large variety of potential deliverables to which a medical writer may author or contribute. Product is used as a broad term to encompass molecules/ drugs, biologics, devices, or other health-science assets. Lists of knowledge, skills, abilities, and behaviors included in the Modal are in alphabetical order, not in order of importance (Table 2) .
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